Brian B. Hansen's most recent trade in Senseonics Holdings Inc was a trade of 5,420 Common Stock done at an average price of $7.2 . Disclosure was reported to the exchange on June 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Senseonics Holdings Inc | Brian B. Hansen | Director, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. | 15 Jun 2026 | 5,420 | 126,937 (0%) | 0% | 7.2 | 38,916 | Common Stock |
| Senseonics Holdings Inc | Brian B. Hansen | Director, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2026 | 124,193 | 124,193 | - | - | Employee Stock Option (right to buy) | |
| Senseonics Holdings Inc | Brian B. Hansen | Director, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2026 | 90,253 | 132,357 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2023 | 407 | 1,219 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2023 | 407 | 12,060 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.06 per share. | 28 Aug 2023 | 135 | 11,925 (0%) | 0% | 27.1 | 3,653 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 474 | 3,320 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 474 | 11,810 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 162 | 1,137 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 162 | 11,390 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.88 per share. | 15 Aug 2023 | 157 | 11,653 (0%) | 0% | 28.9 | 4,534 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.89 per share. | 15 Aug 2023 | 54 | 11,336 (0%) | 0% | 28.9 | 1,560 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 18,037 | 18,037 | - | - | RSU 2023 05 25 | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 8,883 | 8,883 | - | - | PSU 2023 05 25 | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2023 | 406 | 11,363 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2023 | 406 | 1,626 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.57 per share. | 25 May 2023 | 135 | 11,228 (0%) | 0% | 26.6 | 3,587 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 1,897 | 11,584 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 1,897 | 3,794 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 27.32 per share. | 15 May 2023 | 631 | 9,578 (0%) | 0% | 27.3 | 17,239 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.13 per share. | 15 May 2023 | 627 | 10,957 (0%) | 0% | 32.1 | 20,146 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 163 | 1,299 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 163 | 9,741 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.13 per share. | 15 May 2023 | 54 | 9,687 (0%) | 0% | 32.1 | 1,735 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 407 | 9,101 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 407 | 2,032 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.87 per share. | 27 Feb 2023 | 154 | 8,947 (0%) | 0% | 35.9 | 5,524 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 162 | 1,462 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 162 | 8,756 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.11 per share. | 15 Feb 2023 | 62 | 8,694 (0%) | 0% | 43.1 | 2,673 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2022 | 406 | 8,726 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Nov 2022 | 406 | 2,439 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.54 per share. | 28 Nov 2022 | 132 | 8,594 (0%) | 0% | 39.5 | 5,219 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2022 | 163 | 1,624 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2022 | 163 | 8,372 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.26 per share. | 15 Nov 2022 | 53 | 8,319 (0%) | 0% | 42.3 | 2,240 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 36.00 per share. | 15 Nov 2022 | 1 | 8,320 (0%) | 0% | 36 | 36 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Aug 2022 | 407 | 8,342 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Aug 2022 | 407 | 2,845 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.68 per share. | 29 Aug 2022 | 133 | 8,209 (0%) | 0% | 46.7 | 6,208 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 162 | 1,787 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 162 | 7,988 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.25 per share. | 15 Aug 2022 | 53 | 7,935 (0%) | 0% | 55.2 | 2,928 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2022 | 406 | 3,252 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2022 | 406 | 7,958 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.81 per share. | 27 May 2022 | 132 | 7,826 (0%) | 0% | 70.8 | 9,347 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2022 | 650 | 7,457 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2022 | 650 | 1,949 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 61.17 per share. | 16 May 2022 | 306 | 7,552 (0%) | 0% | 61.2 | 18,718 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.85 per share. | 16 May 2022 | 211 | 7,246 (0%) | 0% | 73.8 | 15,582 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 407 | 3,658 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 407 | 6,953 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 112.43 per share. | 28 Feb 2022 | 146 | 6,807 (0%) | 0% | 112.4 | 16,415 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Nov 2021 | 406 | 6,739 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Nov 2021 | 406 | 4,065 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 129.66 per share. | 29 Nov 2021 | 193 | 6,546 (0%) | 0% | 129.7 | 25,024 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2021 | 30,000 | 40,000 | - | - | Stock Option | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.50 per share. | 13 Sep 2021 | 30,000 | 38,513 (0%) | 0% | 51.5 | 1,545,000 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 118.14 per share. | 13 Sep 2021 | 15,000 | 23,513 (0%) | 0% | 118.1 | 1,772,100 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 119.03 per share. | 13 Sep 2021 | 11,800 | 11,713 (0%) | 0% | 119.0 | 1,404,554 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2021 | 2,180 | 0 | - | - | Stock Option | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 120.33 per share. | 13 Sep 2021 | 2,180 | 9,533 (0%) | 0% | 120.3 | 262,319 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.00 per share. | 13 Sep 2021 | 2,180 | 8,513 (0%) | 0% | 9 | 19,620 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 121.68 per share. | 13 Sep 2021 | 1,900 | 7,633 (0%) | 0% | 121.7 | 231,192 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 122.44 per share. | 13 Sep 2021 | 1,300 | 6,333 (0%) | 0% | 122.4 | 159,172 | Common Stock |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2021 | 407 | 6,466 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2021 | 407 | 4,471 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Brian B. Hansen | EVP & CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 110.31 per share. | 27 Aug 2021 | 133 | 6,333 (0%) | 0% | 110.3 | 14,671 | Common Stock |